K940-2355 Screening compound: N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide

K940-2355 Screening compound: N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide
K940-2355 Screening compound: N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K940-2355
N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K940-2355

Molecular Formula

C27H29FN4O3 (C27 H29 FN4 O3)

Compound Name

N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide

IUPAC name

N-[4-(benzyloxy)phenyl]-2-(4-{[(4-fluorophenyl)carbamoyl]methyl}piperazin-1-yl)acetamide

SMILES

O=C(CN1CCN(CC(Nc(cc2)ccc2F)=O)CC1)Nc(cc1)ccc1OCc1ccccc1

InChI

InChI=1S/C27H29FN4O3/c28-22-6-8-23(9-7-22)29-26(33)18-31-14-16-32(17-15-31)19-27(34)30-24-10-12-25(13-11-24)35-20-21-4-2-1-3-5-21/h1-13H,14-20H2,(H,29,33)(H,30,34)

InChI Key

HNNGXHUJJLTWOR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15115241

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.55

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.510

Distribution Coefficient, logD

4.510

Water Solubility, LogSw

-4.42

Polar Surface Area

61.038

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

4.38

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.90

K940-2355 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CNS targets activity set (6557 compounds)

Immunological Library (6760 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Immune system
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
Targets:
  • GPCR
  • Ion Channels
  • Proteases
  • Ion Channels

References: we are preparing a list of scientific research reports with K940-2355 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K940-2355?
Check Price and Availability of K940-2355, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K940-2355 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K940-2355
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K940-2355
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K940-2355 available by request